Preliminary side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy.

ABSTRACT:

Objective(s)

To characterize for the first time the side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy.

Study design

We conducted a secondary analysis of data collected from participants in a three-arm randomized controlled trial (N = 138) aimed at increasing effective contraceptive use among women receiving opioid-agonist therapy. Participants in the 2 intervention conditions (n = 90) had free access to hormonal contraception at each of the 14 visits scheduled during the 6-month intervention. Contraceptive use and side effects were recorded at each visit; participants could change methods or discontinue use at any time. Verbatim side effects were classified using Medical Dictionary for Regulatory Activities (

SUBMITTER: Melbostad HS 

PROVIDER: S-EPMC9317667 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature